Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies
- PMID: 17601626
- DOI: 10.1016/j.diabres.2007.05.004
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies
Abstract
Background: Several estimates of the risk of progression to diabetes in people with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) have been reported.
Objective: To provide an estimate of the risk of progression to diabetes and regression to normoglycemia in these populations.
Design: Systematic overview and meta-analysis of prospective cohort studies published from 1979 until 2004.
Setting: Global cohort studies.
Patients: People with IFG or IGT detected by a screening oral glucose tolerance test.
Measurements: Fasting and post-load plasma glucose levels.
Results: The absolute annual incidence of diabetes in individuals with various categories of IFG or IGT varied from 5 to 10%. Compared to normoglycemic people the meta-analyzed relative risk and 95% confidence interval for diabetes was: 6.35 (4.87-7.82) in people with IGT; 5.52 (3.13-7.91) in people with isolated IGT; 4.66 (2.47-6.85) in people with IFG; 7.54 (4.63-10.45) in people with isolated IFG; and 12.13 (4.27-20.00) in people with both IFG and IGT. People with IGT were 0.33 times as likely to be normoglycemic after 1 year compared to people with normal glucose tolerance (95% CI 0.23-0.43).
Limitations: Studies that used differing criteria for IFG and IGT were included, and participants were classified on the basis of only one test.
Conclusion: IFG and IGT are associated with similar, high relative risk for incident diabetes. The combined abnormality of IFG plus IGT is associated with the highest relative risk.
Similar articles
-
Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.Diabetes Care. 2008 Feb;31(2):267-72. doi: 10.2337/dc07-0912. Epub 2007 Nov 5. Diabetes Care. 2008. PMID: 17989310
-
Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran.Diabetes Metab Res Rev. 2009 Nov;25(8):748-55. doi: 10.1002/dmrr.1038. Diabetes Metab Res Rev. 2009. PMID: 19862775
-
Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.Eur J Clin Invest. 2008 Jun;38(6):389-96. doi: 10.1111/j.1365-2362.2008.01957.x. Eur J Clin Invest. 2008. PMID: 18489400
-
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.Diabet Med. 2002 Sep;19(9):708-23. doi: 10.1046/j.1464-5491.2002.00835.x. Diabet Med. 2002. PMID: 12207806 Review.
-
[Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance].Nihon Rinsho. 2005 Feb;63 Suppl 2:15-20. Nihon Rinsho. 2005. PMID: 15779339 Review. Japanese. No abstract available.
Cited by
-
Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance.Chin Med J (Engl). 2016 Oct 5;129(19):2281-6. doi: 10.4103/0366-6999.190676. Chin Med J (Engl). 2016. PMID: 27647185 Free PMC article. Clinical Trial.
-
Prevalence of Type 2 Diabetes in South Africa: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2021 May 30;18(11):5868. doi: 10.3390/ijerph18115868. Int J Environ Res Public Health. 2021. PMID: 34070714 Free PMC article. Review.
-
Pancreatic beta cell function and insulin resistance profiles in first-degree relatives of patients with prediabetes and type 2 diabetes.Acta Diabetol. 2024 Aug 16. doi: 10.1007/s00592-024-02352-8. Online ahead of print. Acta Diabetol. 2024. PMID: 39150512
-
Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention.Diabetes Educ. 2016 Dec;42(6):667-677. doi: 10.1177/0145721716666678. Epub 2016 Sep 12. Diabetes Educ. 2016. PMID: 27621093 Free PMC article.
-
Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials.J Transl Med. 2019 Dec 5;17(1):410. doi: 10.1186/s12967-019-02159-0. J Transl Med. 2019. PMID: 31805963 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical